Theraputics are medications/treatments designed to combat an infection. This is in contrast to vaccines, which prevent a disease from occuring. As vaccines may not be widely available for some time, theraputics for COVID-19 could play an important role in the epidemic.
This page details potential COVID-19 theraputics. Substances listed here are not necessarily effective. Potential medications are detailed because they are on trial for use in COVID-19 or have been described as a potential treatment in an academic paper.
Anti-virals
- Convalescent plasma
- Remdesivir
- GS-441524
- MK-4482 (formerly known as EIDD-2801)
- Favipiravir
- Hydroxychloroquine and Chloroquine
- Dipyridamole
- Niclosamide
- Nitazoxanide
- Doxycycyline
- Ciclesonide
- Interferons
- Camostat mesylate
- Indomethacin
- Bromhexine
- Galidesivir
- Monoclonal Antibodies
- Amodiaquine
- Soluable ACE2 / ACE2-fc
Host response / anti-inflammatory
- Dexamethasone
- Tocilizumab
- Heparin / enoxaparin
- ARBs
- Baricitinib